These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 27635239)

  • 1. Recent advances in understanding vitiligo.
    Manga P; Elbuluk N; Orlow SJ
    F1000Res; 2016; 5():. PubMed ID: 27635239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Concise Review on the Role of Endoplasmic Reticulum Stress in the Development of Autoimmunity in Vitiligo Pathogenesis.
    Jadeja SD; Mayatra JM; Vaishnav J; Shukla N; Begum R
    Front Immunol; 2020; 11():624566. PubMed ID: 33613564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8.
    Toosi S; Orlow SJ; Manga P
    J Invest Dermatol; 2012 Nov; 132(11):2601-9. PubMed ID: 22696056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitiligo: How do oxidative stress-induced autoantigens trigger autoimmunity?
    Xie H; Zhou F; Liu L; Zhu G; Li Q; Li C; Gao T
    J Dermatol Sci; 2016 Jan; 81(1):3-9. PubMed ID: 26387449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitiligo: Mechanistic insights lead to novel treatments.
    Frisoli ML; Harris JE
    J Allergy Clin Immunol; 2017 Sep; 140(3):654-662. PubMed ID: 28778794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.
    Boniface K; Seneschal J; Picardo M; Taïeb A
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):52-67. PubMed ID: 28685247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into immune mechanisms of vitiligo.
    Boniface K; Taïeb A; Seneschal J
    G Ital Dermatol Venereol; 2016 Feb; 151(1):44-54. PubMed ID: 26512930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of aryl hydrocarbon receptor in vitiligo: a review.
    Li Y; Zeng Y; Chen Z; Tan X; Mei X; Wu Z
    Front Immunol; 2024; 15():1291556. PubMed ID: 38361944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Promising Role of Chemokines in Vitiligo: From Oxidative Stress to the Autoimmune Response.
    He S; Xu J; Wu J
    Oxid Med Cell Longev; 2022; 2022():8796735. PubMed ID: 35096274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic management of vitiligo.
    Bleuel R; Eberlein B
    J Dtsch Dermatol Ges; 2018 Nov; 16(11):1309-1313. PubMed ID: 30335222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding mechanisms of autoimmunity through translational research in vitiligo.
    Strassner JP; Harris JE
    Curr Opin Immunol; 2016 Dec; 43():81-88. PubMed ID: 27764715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Debates on Etiopathogenesis and Treatment Strategies for Vitiligo.
    Chaudhary A; Patel M; Singh S
    Curr Drug Targets; 2022; 23(13):1219-1238. PubMed ID: 35388753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the etiology of contact/occupational vitiligo.
    Boissy RE; Manga P
    Pigment Cell Res; 2004 Jun; 17(3):208-14. PubMed ID: 15140065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nuclear factor (erythroid-derived 2)-like 2 (NRF2) antioxidant response promotes melanocyte viability and reduces toxicity of the vitiligo-inducing phenol monobenzone.
    Arowojolu OA; Orlow SJ; Elbuluk N; Manga P
    Exp Dermatol; 2017 Jul; 26(7):637-644. PubMed ID: 28370349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Oxidative Stress in Vitiligo: An Update on Its Pathogenesis and Therapeutic Implications.
    Chang WL; Ko CH
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the elevated IFN-γ in vitiligo patients by human anti- IFN-γ monoclonal antibody hampers direct cytotoxicity in melanocyte.
    Ng CY; Chan YP; Chiu YC; Shih HP; Lin YN; Chung PH; Huang JY; Chen HK; Chung WH; Ku CL
    J Dermatol Sci; 2023 Jun; 110(3):78-88. PubMed ID: 37221109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and cellular basis of depigmentation in vitiligo patients.
    Delmas V; Larue L
    Exp Dermatol; 2019 Jun; 28(6):662-666. PubMed ID: 30536790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The unfolded protein and integrated stress response in melanoma and vitiligo.
    Manga P; Choudhury N
    Pigment Cell Melanoma Res; 2021 Mar; 34(2):204-211. PubMed ID: 33215847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the unfolded protein response in vitiligo: the missing link?
    Passeron T; Ortonne JP
    J Invest Dermatol; 2012 Nov; 132(11):2502-4. PubMed ID: 23069909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of Different Genes Expressions during Immunological and Inflammatory Responses in Vitiligo.
    Sharma CK; Sharma M; Prasad K
    Crit Rev Eukaryot Gene Expr; 2017; 27(3):277-287. PubMed ID: 29199612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.